In summary, our results have confirmed that inhibiting mTORC1 in the brain microvascular endothelium ameliorates diabetic Aβ brain deposition and cognitive impairment via the SREBP1/LRP1 signaling pathway. The gene discussed is LRP1; the disease is Cognitive impairment.